åžå Žæ°
æå·è³ç£
ã©ã³ãã³ã°
ã«ããŽãªãŒ
éå»ã®ã¹ãããã·ã§ãã
ããŒã¯ã³ã®ããã¯è§£é€
å©åã
å®äžçè³ç£ãªãŒããŒããŒã
ãã¬ã³ã
äžå Žäºå®
æè¿è¿œå ãããã³ã€ã³
äžæçäžäœïŒäžèœçäžäœ
蚪åæ°æå€
ã³ãã¥ããã£ã»ã³ãã¡ã³ã
æ°ç 
ã¯ãªãã
æ¿æ²»
ã¹ããŒã
ãã¡ã€ãã³ã¹
ããã¯
NFTç·åçµ±èš
ä»åŸã®è²©å£²äºå®ããã·ã¥ããŒã
åžå Žæ°
åžæ³æŠèŠ
çŸç©åžå Ž
æå·è³ç£ã®æ°
ãã§ãŒã³ã©ã³ãã³ã°
ãããã³ã€ã³ãã¬ãžã£ãªãŒ
BNBãã¬ãžã£ãªãŒ
ååŒæã®æµå
¥/æµåºã€ã³ãžã±ãŒã¿ãŒ
ææãšåŒ·æ¬²ææ°ã»
ã¢ã«ãã³ã€ã³ã·ãŒãºã³ã€ã³ããã¯ã¹
åžå Žãµã€ã¯ã«ææš
ãããã³ã€ã³ã®ãããã³ã¹
CoinMarketCap 20ã€ã³ããã¯ã¹
CoinMarketCap 100ã€ã³ããã¯ã¹
æå·è³ç£ETF
ãããã³ã€ã³ETF
ã€ãŒãµãªã¢ã ETF
RSI
MACDããªããã£ã
æŠèŠ
æž
ç®
ãã¡ã³ãã£ã³ã°ã¬ãŒã
ã·ã°ãã«
人æ°æ¥äžæ
æ°èŠ
å€äžããéæ
ããŒã ãšã¯ã¹ãããŒã©ãŒ
ããããã¬ãŒããŒååŒæ
äžå€®éæš©åååŒæ
çŸç©
ããªããã£ãåæ£åååŒæ
çŸç©
ããªããã£ã
ãã£ãŒã
ãããã¯
ã©ã€ã
èšäºäžèŠ§
æå·è³ç£API
DEX API
ãšã³ã¿ãŒãã©ã€ãº
å°å
¥äºäŸ
æé
ãªãœãŒã¹
ããã¥ã¡ã³ããŒã·ã§ã³
ãããã質å
CMCãšãŒãžã§ã³ããã
ã¹ãã«ããŒã±ãããã¬ã€ã¹
CMC MCP
x402ãããã¯ã
ãããã¯ã
ã³ã³ããŒã¿ãŒ
ãã¥ãŒã¹ã¬ã¿ãŒ
CMC Launch
CMCã©ã
CMC Max
Telegramããã
åºåæ²èŒã«ã€ããŠ
ãµã€ããŠã£ãžã§ãã
ãã¥ãŒã¹
ã¢ã«ãããŒ
ãªãµãŒã
ãããªäžèŠ§
æå·è³ç£çšèªé
AIã¢ã©ãŒããã£ã³ããŒã³
ãšã¢ãããã
ãã€ã€ã¢ã³ãã»ãªã¯ãŒã
åŠãã§çšŒãã«ã¬ã³ããŒ
ICOã«ã¬ã³ããŒ
ã€ãã³ãã«ã¬ã³ããŒ
Merck & Co IncMRK#36
#36
ï¿¥22,253.56Â Â
çµäº: Sep 11, 20:00:00 PM UTC+00:000.53%
ï¿¥22,496.31Â Â
ãã¬ããŒã±ãã: Sep 14, 10:28:36 AM UTC+00:001.09%
Merck & Co Inc Info
- æ䟡ç·é¡
- ï¿¥55.5T
1.09%
- äžæ¥ããªã¥ãŒã
- ï¿¥155.56M
- æ ªäŸ¡åçç
- 111.91
- é åœå©åã
- 2.34%
- EPS
- ï¿¥199.45
- 52é±ã¬ã³ãž
- ï¿¥11.99Kï¿¥24.26K
ãŠã§ããµã€ã
è³ç£ã¿ã€ã
æ ªåŒ
åŸæ¥å¡
75000
èšç«
Jan 1, 1891
äž»èŠååŒæ
New York Stock Exchange
æ¥çš®
Pharmaceutical Preparations
CIKçªå·
0000310158
ããŒã¯ã³åæ ªåŒããŒã¿
- å¹³åããŒã¯ã³åäŸ¡æ Œ
- ï¿¥22.64K
- äŸ¡æ Œå·®
- +ï¿¥144.25(+0.64%)
- ããŒã¯ã³åè³ç£æ䟡ç·é¡
- ï¿¥47.86M
0.3%
- ããŒã¯ã³ååºæ¥é«ïŒ24æéïŒ
- ï¿¥108.38M
4.09%
MRKããUSDãžã®äº€æ
MRK
JPY
äŸ¡æ Œããã©ãŒãã³ã¹
å®
ï¿¥22.33K
ï¿¥22.33K
é«
ï¿¥22.49K
ï¿¥22.49K
èªã¿èŸŒã¿äž...
ãåŸ ã¡ãã ããããã£ãŒãããŒã¿ãèªã¿èŸŒãã§ããŸã
Merck & Co Inc Community
Â
Â
Â
Â
Â
Â
Merck & Co Incã«ã€ããŠ
What is Merck & Co Inc?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
人æ°ã®ãªã¢ã«ã¯ãŒã«ãã¢ã»ãã
Merck & Co Inc äŸ¡æ Œã®çé ä¿¡ããŒã¿
Merck & Co Incã®çŸåšã®åžå ŽäŸ¡æ Œã¯ï¿¥22,496.31ã24æéã®ååŒé«ã¯ï¿¥155.56Mã§ãããã®è³ç£ã®æ䟡ç·é¡ã¯ãéå»24æéã§1.09%å€åããï¿¥55.5Tãšãªã£ãŠããŸãã
ããŒã¯ã³åãããMerck & Co Incã¯ï¿¥22,640.56ã§ååŒãããŠãããããŒã¯ã³åãããæ䟡ç·é¡ã¯ï¿¥47.86Mã24æéã®ååŒé«ã¯ï¿¥108.38Mã§ãããã®ããŒã¯ã³åãããè³ç£ã¯ãéå»24æéã§-0.30%å€åããŸããã